Lite Strategy, Inc.

LITS

$1.04

+0.00%

N/A+$0.00

Healthcare

Biotechnology

NASDAQ

Active Trading

Lite Strategy, Inc. functions as a clinical-stage pharmaceutical firm, concentrating its efforts on creating innovative and distinct therapeutic solutions for cancer patients. ...

Insider Transactions of LITS

Acquisitions (A)

Since Nov 14, 2025

Disposals (D)

Since Nov 14, 2025

Monthly shares of acquisitions/disposals with close price trend (shared daily price source)

Insider Trading Snapshot

Date	Executive	Title	Security	Side	Shares	Price
Jun 24, 2026	Flynn James P	director	Common Stock	A	25,000	$0.86
Feb 12, 2026	File Justin J.	director, officer: CEO, CFO and Secretary	Stock Option (Right to Buy)	A	455,000	$2.02
Dec 19, 2025	Flynn James P	director	Common Stock	A	70,000	$1.40
Dec 18, 2025	Schornstein Alexander	10 percent owner	Common Stock	D	690,611	$1.37
Nov 19, 2025	Flynn James P	director	Common Stock	A	12,100	$1.88

Insider Trading Snapshot

Acquisitions (A)

Disposals (D)

Total Shares Bought

917,100

Total Shares Sold

690,611

Monthly Insider Activity

Monthly shares of acquisitions/disposals with close price trend (shared daily price source)

Transactions by Title - Shares

X-axis: shares, sorted by total shares desc

Transactions by Title - Counts

X-axis: counts, sorted by A+D counts desc

Key People: Buy/Sell Activity and Price

File Justin J.

director, officer: CEO, CFO and Secretary • 2 txns

Flynn James P

director • 3 txns

Riezman Joshua

director • 2 txns

Schornstein Alexander

10 percent owner • 1 txns

Transactions Table

Date	Executive	Title	Security	Side	Shares	Price	Value
Jun 24, 2026	Flynn James P	director	Common Stock	A	25,000	$0.86	$21,387.50
Feb 12, 2026	File Justin J.	director, officer: CEO, CFO and Secretary	Stock Option (Right to Buy)	A	455,000	$2.02	$919,100.00
Dec 19, 2025	Flynn James P	director	Common Stock	A	70,000	$1.40	$97,699.00
Dec 18, 2025	Schornstein Alexander	10 percent owner	Common Stock	D	690,611	$1.37	$946,137.07
Nov 19, 2025	Flynn James P	director	Common Stock	A	12,100	$1.88	$22,777.04
Nov 14, 2025	File Justin J.	director, officer: CEO, CFO and Secretary	Stock Option (Right to Buy)	A	180,000	$2.02	$363,600.00
Nov 14, 2025	Glover Nicholas	director	Stock Option (Right to Buy)	A	55,000	$2.02	$111,100.00
Nov 14, 2025	DRISCOLL FREDERICK W	director	Stock Option (Right to Buy)	A	55,000	$2.02	$111,100.00
Nov 14, 2025	Riezman Joshua	director	Stock Option (Right to Buy)	A	55,000	$2.02	$111,100.00
Nov 14, 2025	Riezman Joshua	director	Stock Option (Right to Buy)	A	10,000	$2.02	$20,200.00

Upstream

Presage Biosciences, Inc.GSR (Global Standard Research / GSR Markets Ltd.)Litecoin FoundationCharlie Lee (individual advisor / Non-Executive Director)Piramal Phytocare Ltd. (division of Piramal Enterprises Ltd.)BSE:500302Cryptocurrency Exchanges & OTC Desks (multiple, unnamed)Unnamed CDMO / CRO Partners (Pharma legacy)

Downstream

Institutional & Retail Equity InvestorsUnconfirmedKyowa Kirin Co., Ltd.TSE:4151Unnamed Buyer of ME-344 (renamed WE-868)Litecoin (LTC) Spot & Derivatives Markets

Proxies

MicroStrategy Incorporated (renamed Strategy)NASDAQ:MSTRGalaxy Digital Holdings Ltd.TSX:GLXYCoinbase Global, Inc.NASDAQ:COIN Mogo Inc.NASDAQ:MOGO

About UsPrivacy PolicyTerms of ServiceDisclaimerStock DirectoryETFsIndices13F HoldingsAnalyst TargetsFree ToolsTechnology MapJoin our Slack

Plutux is not an investment adviser. Market data and AI-generated analysis are for information and education only, not investment advice. Disclaimer

No matching stocks found

Lite Strategy, Inc.

Insider Transactions of LITS

Insider Trading Snapshot

Monthly Insider Activity

Transactions by Title - Shares

Transactions by Title - Counts

Key People: Buy/Sell Activity and Price

Transactions Table

Supply Chain of LITS

Upstream

Downstream

Proxies

Insider Transactions of LITS

Insider Trading Snapshot

Monthly Insider Activity

Transactions by Title - Shares

Transactions by Title - Counts

Key People: Buy/Sell Activity and Price

Transactions Table

Supply Chain of LITS

Upstream

Downstream

Proxies